Citation Impact
Citing Papers
Role of LBPA and Alix in Multivesicular Liposome Formation and Endosome Organization
2004 StandoutScienceNobel
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy
2001
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Combinatorial Cancer Immunotherapy
2006
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer
2000
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis
2006 Standout
Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of HLA class II molecules
1999
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome: North American experience
1995
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
2015
Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium
1992
Loop electrosurgical excision procedure of the cervix and time of delivery in subsequent pregnancy
2001
Molecular Cloning of the CA125 Ovarian Cancer Antigen
2001
In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides
1995
Human tumor antigens recognized by T-cells
1997
The Hallmarks of Cancer
2000 Standout
Developmental regulation of MHC class II transport in mouse dendritic cells
1997 StandoutNatureNobel
Structure of peptides associated with MHC class I molecules
1994
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective
1996
Breast cancer genomes — form and function
2010
O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy
2001
The impact of T‐cell immunity on ovarian cancer outcomes
2008
MUC1: the polymorphic appearance of a human mucin
2000
Human tumor antigens for cancer vaccine development
1999
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Human Peritoneal Mesothelial Cells Are More Potent Than Ovarian Cancer Cells in Producing Tumor Marker CA-125
1996
The natural history of cervical HPV infection: unresolved issues
2006
Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP
2003
Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes
1998
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
1996 Standout
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs
1994 StandoutNatureNobel
A Novel Lysosome-Associated Membrane Glycoprotein, DC-LAMP, Induced upon DC Maturation, Is Transiently Expressed in MHC Class II Compartment
1998
Programmed cell removal: a new obstacle in the road to developing cancer
2011
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Community-Based Prevalence of Anal Incontinence
1995 Standout
Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening
2005
Dendritic cell maturation and antigen presentation in the absence of invariant chain
1998
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULES
1997
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
2000 StandoutNobel
Tumor immune escape mechanisms: impact of the neuroendocrine system
2006
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells
2001
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
2002
The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat Sequences
2001
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
CA125 in Ovarian Cancer
2007
B lymphocytes secrete antigen-presenting vesicles.
1996 Standout
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells
2003
Major Histocompatibility Complex Class II Compartments in Human and Mouse B Lymphoblasts Represent Conventional Endocytic Compartments
1997
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli
2000 StandoutNobel
The cancer antigen CA125 represents a novel counter receptor for galectin-1
2003
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
1995 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells
2000 StandoutScienceNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
More than 15 Years of CA 125: What is Known about the Antigen, Its Structure and Its Function
1998
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface.
1996
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
1997
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
1994
Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study
2001
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
1994
Germ Cell Tumors
1992
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Rat Spleen Dendritic Cells Express Natural Killer Cell Receptor Protein 1 (NKR-P1) and Have Cytotoxic Activity to Select Targets via a Ca2+-dependent Mechanism
1997
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of Peter Kenemans being referenced
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer
2001
Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian Carcinoma
1995
High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy
2000
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients
2001
Oncogenic pathways in hereditary and sporadic breast cancer
2004
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
1993
CA 125 in gynecological pathology — a review
1993
Urinary and Faecal Incontinence in Community-residing Elderly Women
1992
Quantification of MUC1 in breast cancer patients
1999
Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study
1999
An Enzyme-Linked Immunosorbent Assay for the Measurement of Circulating Antibodies to Polymorphic Epithelial Mucin (MUC1)
1998
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients
1995
Use of Serum Tumor Markers in the Differential Diagnosis between Ovarian and Colorectal Adenocarcinomas
1992
Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours
1994
Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values
1996
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours
1996
The Second Generation CA125 Assays
1995
Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes
1993
Reprint of Oncogenic pathways in hereditary and sporadic breast cancer
2008
CA 125: fundamental and clinical aspects
1999
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
1999
Diathermy loop excision in the management of cervical intraepithelial neoplasia: Diagnosis and treatment in one procedure
1992
Fluctuations in CA 125 and CA 15 3 serum concentrations during spontaneous ovulatory cycles
1999
Characterization of a New MUC1 Monoclonal Antibody (VU-2-G7) Directed to the Glycosylated PDTR Sequence of MUC1
2000
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides andn-acetylgalactosamine (GalNAc) peptides
2000
Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction
1990
Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
1997
MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
1993
Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin
2000
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
1995
Monoclonal Antibody Against Human Ovarian Tumor-Associated Antigens
1986
Human MUC1 Mucin: A Multifaceted Glycoprotein
2000
Serum CA-125 in Relation to Adnexal Dysplasia and Cancer in Women at Hereditary High Risk of Ovarian Cancer
2007
Prognostic Factors in Borderline and Invasive Ovarian Tumours of the Common Epithelial Type
1987